NCT01587131 arm group 52b93f7409d39c39d40d258999971572 [clinicaltrials_resource:NCT01587131/arm-group/52b93f7409d39c39d40d258999971572]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01587131 arm group 52b93f7409d39c39d40d258999971572 [clinicaltrials_resource:NCT01587131/arm-group/52b93f7409d39c39d40d258999971572]
Bio2RDF identifier
NCT01587131/arm-group/52b93f7409d39c39d40d258999971572
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... b93f7409d39c39d40d258999971572
description [clinicaltrials_vocabulary:description]
0.9 mg FVH1 vaccine delivered ...... accine delivered IM on Week 15
identifier
clinicaltrials_resource:NCT01587131/arm-group/52b93f7409d39c39d40d258999971572
title
NCT01587131 arm group 52b93f7409d39c39d40d258999971572
@en
type
label
NCT01587131 arm group 52b93f74 ...... 93f7409d39c39d40d258999971572]
@en